Growth Hormone Therapy for a Child With Severe Cognitive Impairment.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 30237229.
- Also identified by DOI 10.1542/peds.2017-3938.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The expansion of growth hormone therapy over the last 3 decades has allowed for treatment of short stature for more children, resulting in increased height for many. However, treatment of idiopathic short stature remains controversial. Treatment decisions for disabled children with idiopathic short stature are even more complicated. We discuss a specific case of short stature in a disabled child and grapple with the ethical issues involved in the use of growth hormone.
Medical subject headings
- Clinical Decision-Making
- Cognitive Dysfunction
- Human Growth Hormone
- Severity of Illness Index